Deep Brain Stimulation
... required to provide definitive evidence of efficacy, but only probable benefit. As noted in the FDA’s analysis of risk and probable benefit, the only other treatment options for chronic refractory primary dystonias are neurodestructive procedures. DBS provides a reversible alternative. The FDA summa ...
... required to provide definitive evidence of efficacy, but only probable benefit. As noted in the FDA’s analysis of risk and probable benefit, the only other treatment options for chronic refractory primary dystonias are neurodestructive procedures. DBS provides a reversible alternative. The FDA summa ...
Antiepileptic Drugs
... • Control achieved easily on one drug at low dose • No previous unsuccessful attempts at withdrawal • Normal neurologic exam and EEG • Primary generalized seizures except JME ...
... • Control achieved easily on one drug at low dose • No previous unsuccessful attempts at withdrawal • Normal neurologic exam and EEG • Primary generalized seizures except JME ...
Goals and Objectives of Training in Clinical Neurophysiology
... The residents will spend more time in their area of emphasis (any one of the above); however, the overall goal of training is to become proficient in two of the three major areas and be sufficiently familiar with the basics and common disorders in the third area that after the completion of the trai ...
... The residents will spend more time in their area of emphasis (any one of the above); however, the overall goal of training is to become proficient in two of the three major areas and be sufficiently familiar with the basics and common disorders in the third area that after the completion of the trai ...
MIAME Checklist
... Microarray Analysis Suite 5.0. For a gene to be included, it had to be present (detectable) in at least 75% of the subjects in at least 1 of the 2 groups (Parkinson’s disease patients and controls) to reduce the chances of false-positive findings. Expression data were analyzed using Genesis (GeneLog ...
... Microarray Analysis Suite 5.0. For a gene to be included, it had to be present (detectable) in at least 75% of the subjects in at least 1 of the 2 groups (Parkinson’s disease patients and controls) to reduce the chances of false-positive findings. Expression data were analyzed using Genesis (GeneLog ...
![Paraneoplastic Syndrome [PPT]](http://s1.studyres.com/store/data/003385532_1-2243b1ebb348b1947bb80fed296c84e4-300x300.png)
Anxiety! - neuropsychII
... – School psychologist can play active role in educating administrators and teachers to recognize symptoms and understand prevalence – Many commonly feared situations occur in school ...
... – School psychologist can play active role in educating administrators and teachers to recognize symptoms and understand prevalence – Many commonly feared situations occur in school ...
Phantosmia
Phantosmia is an olfactory hallucination. A hallucination is the sensory perception of something with no basis in reality, as opposed to an olfactory illusion, which is a misinterpretation of a physical stimulus; in the case of an odor it is known as parosmia. Phantosmia is the perception of a smell in the complete absence of any physical odor. The perceived odor can range from pleasant to disgusting. Although the causes of phantosmia are uncertain, it often occurs with neurological and psychological disorders such as schizophrenia, mood disorders, Parkinsons disease, epilepsy, neuroblastoma, and frequent migraines.Galen also mentioned olfactory hallucinations in his work and stated that these hallucinations constitute the signs of an oncoming disease.Different types of phantosmia include: Unirhinal (single nostril), episodic, and recurrent, where the activation of brain's GABAergic system seems to play a role in the inhibition of the unirhinal phantosmia.Treatments for phantosmia range from drug therapies (e.g., venlafaxine) and brain stimulation therapies to invasive surgical procedures involving removal of the olfactory bulbs or olfactory epithelium.The word phantosmia is a noun of Greek origin. It is composed of two words: (1) phant- meaning ""phantom"" and (2) -osmia (from osme) meaning ""smell"".